Breaking News: Takeda Settles Actos Lawsuits for $2.37 Billion
Takeda Pharmaceuticals agreed to settle thousands of pending Actos bladder cancer lawsuits for $2.37 billion.| Drugwatch.com
Takeda Pharmaceuticals agreed to settle thousands of pending Actos bladder cancer lawsuits for $2.37 billion.| Drugwatch.com
Diabetes drugmakers faced lawsuits for side effects such as cancer and stomach paralysis. Learn more about legal claims.| Drugwatch.com
The Cymbalta lawsuit stemmed from previous users claiming the drug caused severe withdrawal symptoms and suicidal thoughts - some cases ended in death.| Drugwatch.com
Approved in 2004, Cymbalta is an SNRI that treats depression, anxiety and pain disorders by preventing the body from reabsorbing certain neurotransmitters.| Drugwatch.com
Type-2 diabetes medication Actos is linked to serious side effects such as congestive heart failure and bladder cancer.| Drugwatch.com
